Hikma Pharmaceuticals PLC
HKMPY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $455,000 | $281,000 | $233,000 | $544,000 |
| Dep. & Amort. | $197,000 | $198,000 | $193,000 | $145,000 |
| Deferred Tax | $0 | $0 | $0 | -$89,000 |
| Stock-Based Comp. | $27,000 | $25,000 | $22,000 | $29,000 |
| Change in WC | -$135,000 | $80,000 | -$131,000 | -$30,000 |
| Other Non-Cash | $20,000 | $24,000 | $213,000 | $39,000 |
| Operating Cash Flow | $564,000 | $608,000 | $530,000 | $638,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$165,000 | -$169,000 | -$225,000 | -$229,000 |
| Net Acquisitions | -$162,000 | -$105,000 | -$380,000 | -$17,000 |
| Inv. Purchases | -$2,000 | -$27,000 | -$15,000 | -$3,000 |
| Inv. Sales/Matur. | $0 | $1,000 | $0 | $6,000 |
| Other Inv. Act. | -$52,000 | -$33,000 | $13,000 | $5,000 |
| Investing Cash Flow | -$381,000 | -$333,000 | -$607,000 | -$238,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $124,000 | -$93,000 | $456,000 | -$83,000 |
| Stock Issued | -$38,000 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$300,000 | $0 |
| Dividends Paid | -$175,000 | -$137,000 | -$125,000 | -$120,000 |
| Other Fin. Act. | -$99,000 | -$107,000 | -$89,000 | -$84,000 |
| Financing Cash Flow | -$188,000 | -$337,000 | -$58,000 | -$287,000 |
| Forex Effect | -$12,000 | -$3,000 | -$21,000 | -$10,000 |
| Net Chg. in Cash | -$17,000 | -$65,000 | -$156,000 | $103,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $205,000 | $270,000 | $426,000 | $323,000 |
| End Cash | $188,000 | $205,000 | $270,000 | $426,000 |
| Free Cash Flow | $329,000 | $404,000 | $305,000 | $409,000 |